Clinical trial
Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus…
NCT00043927 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00043927 |
|---|---|
| Title | Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults |
| Official title | An Open-Label, Multicenter, Randomized, Phase III Study Comparing Oral Topotecan/Cisplatin Versus Etoposide/Cisplatin as Treatment for Chemotherapy-naive Patients With Extensive Disease-Small Cell Lung Cancer. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | topotecan/cisplatin, etoposide/cisplatin |
| Enrollment | 760 |
| Start date | Apr 1, 2001 |
| Primary completion | Jan 1, 2004 |
| First posted | Aug 16, 2002 |
| Last update posted | Aug 21, 2013 |
| Countries | Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Costa Rica, Czechia, Estonia, Finland, France and 22 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: